The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.
Of death?
The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants.
Based on...?
are authorized under emergency use for individuals 6 months through 11 years of age
Emergency?
The updated mRNA vaccines are manufactured using a similar process as previous formulations.
That instills a lot of confidence.
the benefit-risk profile is favorable for individuals 6 months of age and older to receive an updated COVID-19 mRNA vaccine
Favorable to whom?
All I want to know is,
(post is archived)